United States· US:72789-524_3e794c61-ef94-8751-e063-6294a90aafc4
Minocycline Hydrochloride
A minocycline product containing minocycline hydrochloride, registered in United States by PD-Rx Pharmaceuticals, Inc.. The same ATC class is registered in 10 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Minocycline is registered in 10 of 19 countries.
Countries holding a registration under ATC J01AA08 (minocycline), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 4 of them publish a price we can compare per daily dose
Minocycline · ATC J01AA08
10 / 19 countries
- Belgiumprice
- Canada
- Germany
- Ireland
- Japan
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- MINOCYCLINE HYDROCHLORIDE
- Manufacturer
- PD-Rx Pharmaceuticals, Inc.
- Country
- United States (US)
- ATC code
- J01AA08
- ATC class
- Minocycline
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- August 2, 2026
Packs & prices · 2
- ndc11727895243030 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (72789-524-30)
- ndc1172789-524-30
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
367 interactions on record for minocycline.
Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Minocycline · interactions on record
367 records
- 15 severe
- 142 moderate
- 28 minor
- 128 info
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- AcitretinD05BB02severe
- IsotretinoinD10AD04severe
54 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Minocycline in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAcnamino MR 100mg capsulesAlmus Pharmaceuticals Ltd
- BelgiumKlinotab 100 mgTeofarma
- NorwayMinocinTeofarma
- NetherlandsMinocycline Aurobindo 100 mg, omhulde tablettenAurobindo Pharma B.V.
- CanadaARESTIN MICROSPHERESORA PHARMA INC.
- GermanyMinoplusChephasaar Chemisch-Pharmazeutische Fabrik Gmbh
- IrelandMinocin SA 100 mg Modified Release CapsulesViatris Healthcare Limited
- FranceMYNOCINE 100 mg, géluleLABORATOIRE XO
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Austria · Minostad
- Belgium · Klinotab, Mino-50
- Bulgaria · Миноциклин Екофарм
- Cyprus · Minaxen
- Germany · Minoplus, Skid
- Spain · Minocin Vía Oral
- France · Kyno, Mynocine
- United Kingdom (Northern Ireland) · Dentomycin, Minocin Mr
- Greece · Minocin
- Ireland · Minocin Sa, Minosil
- Italy · Minocin
- Luxembourg · Klinotab, Mino
- Malta · Minaxen
- Netherlands · Minocycline Eurogenerics, Minocycline Hydrochloride Dihydrate Aurobindo
- Portugal · Cipancin, Minocin
- Romania · Minoz Ep
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c200186d-0c38-4fe1-941f-b40486dd451e GET /v1/drugs/c200186d-0c38-4fe1-941f-b40486dd451e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "65",
"substance": "MINOCYCLINE HYDROCHLORIDE",
"productndc": "72789-524",
"dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA204453",
"marketing_category": "ANDA"
}See everything about minocycline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.